289039-54-9 Usage
General Description
Ethyl 2-chloro-5-iodobenzoate is an organic chemical compound with the molecular formula C9H8ClIO2. It is derived from benzoic acid and contains a chlorine and iodine atom, as well as an ester group. Ethyl 2-chloro-5-iodobenzoate is commonly used in organic synthesis and as an intermediate in various chemical reactions. It is often used in the production of pharmaceuticals, agrochemicals, and other fine chemicals. The 2-chloro-5-iodobenzoate group within the molecule provides a versatile platform for further functionalization, making it a valuable building block in organic chemistry. Additionally, its reactivity and unique properties make it an important reagent in the field of chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 289039-54-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,9,0,3 and 9 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 289039-54:
(8*2)+(7*8)+(6*9)+(5*0)+(4*3)+(3*9)+(2*5)+(1*4)=179
179 % 10 = 9
So 289039-54-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H8ClIO2/c1-2-13-9(12)7-5-6(11)3-4-8(7)10/h3-5H,2H2,1H3
289039-54-9Relevant articles and documents
New Pyrazolecarboxylic compd., its manufacturing method and pest control agents
-
Paragraph 0176; 0177; 0178, (2018/05/03)
PROBLEM TO BE SOLVED: To provide a new pyrazole compound capable of showing excellent biological activity to not only spider mites but also Nematoda. SOLUTION: It is found that a new pyrazole compound having a nitrogen-containing hetero ring in a first position of a pyrazole ring and a sulfonate group in a fifth position shows excellent biological activity to not only the spider mites but also the Nematoda. COPYRIGHT: (C)2012,JPOandINPIT
4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
-
Paragraph 0565-0568; 0577, (2014/03/21)
The invention relates to 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalene derivatives of general formula (I) which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous system diseases and other diseases. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture the compounds according to the invention.